Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024

Media Release Complete Response Patient Case Study The patient with a confirmed complete response (CR) was diagnosed with triple-negative breast carcinoma (TNBC) in 2019 and has failed multiple lines of therapy including a CDK 4/6 inhibitor for ER+/PR+ metastasis. During the immuno-oncology (IO)-chemotherapy treatment of efti and paclitaxel, this patient achieved a partial response (PR) that subsequently turned into a CR. This patient's ongoing CR has been maintained since stopping paclitaxel and being trea ...